Trial reportJournal of clinical hypertension (Greenwich, Conn.)2020
Prevalence and clinical outcomes of patients with apparent treatment-resistant hypertension enrolled in Phase 2 cardiac rehabilitation.
Trial report in Journal of clinical hypertension (Greenwich, Conn.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 2 citations in OpenAlex.
- Prevalence and clinical outcomes of patients with apparent treatment-resistant hypertension enrolled in Phase 2 cardiac rehabilitation.Journal of clinical hypertension (Greenwich, Conn.) · 2020Trial
- Microvascular Dysfunction Following Cardioplegic Arrest and Cardiopulmonary Bypass: Impacts of Diabetes and Hypertension.Biomedicines · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Phase 2 cardiac rehabilitation (CR) employs evidenced-based interventions to modify the risk of cardiac morbidity in its participants. The prevalence of apparent treatment-resistant hypertension (aTRH) among CR participants is unknown. A retrospective analysis of a longitudinal cohort of patients who completed CR between 2012 and 2017 was undertaken. The prevalence of hypertension was 62% (n = 311). 11% of participants with hypertension had aTRH (n = 35). Participants with aTRH exhibited lower exercise capacity (EC) before starting CR and after its completion compared to normotensive counterparts (P < .001). aTRH participants were more likely to experience a decrease in EC, even after participating in cardiac rehabilitation, compared to normotensive participants (P = .02). aTRH participants were more likely to be hospitalized or seen in the emergency department after cardiac rehabilitation completion compared to normotensive counterparts (OR: 2.85, P < .01). CR presents an opportunity to identify and appropriately care for patients with aTRH.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.